Recent extremely meaningful negative changes in investment behavior have impacted OptimizeRX Corp (NASDAQ: OPRX): the stock’s recent price decline challenged its longer term uptrend, and its shorter term price trend turned down.
OptimizeRX Corp (NASDAQ: OPRX) has recently experienced significant negative changes in fundamentals: the consensus estimate for December, 2024 decreased significantly, and the consensus estimate for December, 2025 decreased significantly.
In light of these highly negative signals we are reviewing our current Overall Rating of C. We would view the shares with caution pending completion of this review in the next several days.
Current PriceTarget Research Rating
With future capital returns forecasted to exceed the cost of capital, OPRX is expected to be a modest Value Builder.
OptimizeRX has a current Value Trend Rating of C (Low Neutral). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. OptimizeRX has a poor Appreciation Score of 17 but a good Power Rating of 76, resulting in the Low Neutral Value Trend Rating.
Recent Price Action
OptimizeRX Corp (NASDAQ: OPRX) stock declined modestly by -1.5% on 6/21/24. The stock closed at $10.57. However, unusually low trading volume at 62% of normal accompanied the decline. The stock has been strong relative to the market over the last nine months but has declined -9.7% during the last week.
Be the first to comment